| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/2008 | US20080039325 Nucleic acid molecule having promoter activity; expressing herbicide tolerance gene in plants |
| 02/14/2008 | US20080039324 Actin regulatory elements for use in plants |
| 02/14/2008 | US20080039323 Nucleic acid molecule having promoter activity; expressing herbicide tolerance gene in plants |
| 02/14/2008 | US20080038844 Method of Analyzing Nucleic Acids Using an Array of Encoded Beads |
| 02/14/2008 | US20080038825 L-Amino Acid-Producing Bacterium and Method for Producing L-Amino Acid |
| 02/14/2008 | US20080038824 Composition and Method for Elevating Gene Transfer Efficiency |
| 02/14/2008 | US20080038822 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/14/2008 | US20080038819 Micro Rna Inhibiting the Expression of Wt1 Gene and Utilization of the Same |
| 02/14/2008 | US20080038799 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038798 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids |
| 02/14/2008 | US20080038797 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038796 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038795 Polyunsaturated fatty acids (PUFA); from Shewanella japonica and Shewanella olleyana; beta -ketoacyl-ACP acyltransferase activity; recombinant microbial, plant cells |
| 02/14/2008 | US20080038794 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038793 Transformed microorganism such as bacteria for polyunsaturated fatty acid (PUFA) synthesis on commercial scale |
| 02/14/2008 | US20080038792 Polyunsaturated fatty acids (PUFA); FabA-like beta-hydroxy acyl-ACP dehydrase activity and enoyl ACP-reductase activity; recombinant plant/microbial cells |
| 02/14/2008 | US20080038791 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038790 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038781 Biosynthesis of of inosine and guanosine in E coli modified to block a reaction catalyzed by succinyl-adenosine monophosphate synthase |
| 02/14/2008 | US20080038777 Synthetic dog/human chimeric C-C chemokine receptor 2B |
| 02/14/2008 | US20080038748 Antibodies That Recognize Cutting Edge Within The Tgf-Beta Activation Controlling Region |
| 02/14/2008 | US20080038741 T1R taste receptors and genes encoding same |
| 02/14/2008 | US20080038735 Tus DNA binding domains |
| 02/14/2008 | US20080038728 Quadruple Transformed Cell Line Useful for the Identification of Transport Inhibitors |
| 02/14/2008 | US20080038723 Functional assessment of DNA mismatch repair gene variants |
| 02/14/2008 | US20080038722 performing a bioassay on a sample to determine the sequence of an allele of the P2X1 promoter gene, to determine the to likelihood of developing peripheral vascular disease, strokes and myocardial necrosis; screening for anticoagulants |
| 02/14/2008 | US20080038721 Sequence Capable Of Accelerating Gene Expression At Moderately Low Temperature |
| 02/14/2008 | US20080038718 Method For Parallelly Sequencing A Nucleic Acid Mixture By Using a Continuous Flow System |
| 02/14/2008 | US20080038717 Enrichment method for variant proteins with altered binding properties |
| 02/14/2008 | US20080038716 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 02/14/2008 | US20080038379 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038378 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038366 Actin regulatory elements for use in plants |
| 02/14/2008 | US20080038349 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038296 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 02/14/2008 | US20080038293 compositions provide immune response up to and including protective immunity against porcine reproductive and respiratory syndrome (PRRS) as well as reduce the severity of PRRS virus (PRRSV) and/or incidence of PRRSV |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038285 Method for Identifying and Quantifying of Tumour-Associated |
| 02/14/2008 | US20080038284 Human Immunodeficiency Virus Vaccine |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038260 specifically bind to monocyte-derived dendritic cells (MDDC); immunostimulants; downmodulating transplant rejection; cancer |
| 02/14/2008 | US20080038257 Hepatocyte growth factor (hgf) binding proteins |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof |
| 02/14/2008 | US20080038244 Materials and Methods Relating to Cell Cycle Control |
| 02/14/2008 | US20080038235 Methods for regulating T cell subsets by modulating transcription factor activity |
| 02/14/2008 | US20080038234 Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair |
| 02/14/2008 | US20080038232 Production of high mannose proteins in plant culture |
| 02/14/2008 | US20080038227 Animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof |
| 02/14/2008 | US20080038224 Modified interferon-beta (IFN-beta) polypeptides |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038200 Model for neurodegenerative diseases involving amyloid accumulation |
| 02/14/2008 | US20080038198 Method Of Screening Molecule Associated With Psychiatric Disorder |
| 02/14/2008 | US20080038189 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy |
| 02/14/2008 | US20080035482 Method Of Concentrating And Purifying Nucleic Acid And Apparatus Therefor |
| 02/14/2008 | US20080034862 Fluid Flow Meter Body With High Immunity to Inlet/Outlet Flow Disturbances |
| 02/14/2008 | DE102006037581A1 Citrusal-Duftstoffrezeptoren Citrusal Perfume receptors |
| 02/14/2008 | CA2695951A1 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
| 02/14/2008 | CA2695306A1 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 02/14/2008 | CA2694984A1 Oligonucleotides for discriminating related nucleic acid sequences |
| 02/14/2008 | CA2660523A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 02/14/2008 | CA2660438A1 Genes and polypeptides relating to breast cancers |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2660324A1 Plasmids with immunological action |
| 02/14/2008 | CA2660143A1 Genomics-based quality diagnostics for fresh agricultural products |
| 02/14/2008 | CA2660040A1 Method of increasing resistance against soybean rust in transgenic plants |
| 02/14/2008 | CA2659631A1 Antibodies to erbb2 |
| 02/14/2008 | CA2659535A1 Genetically modified plants which synthesize a starch having increased swelling power |
| 02/14/2008 | CA2659437A1 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 02/14/2008 | CA2650505A1 Ethanol production in non-recombinant hosts |
| 02/13/2008 | EP1887364A1 Substrate for biochip and biochip |
| 02/13/2008 | EP1887089A1 Method of detecting hybridization by using intercalator |
| 02/13/2008 | EP1887085A1 Process for production of optically active 2-substituted propanal derivative |
| 02/13/2008 | EP1887084A1 Plasmids with immunological action |
| 02/13/2008 | EP1887083A1 Use of the 5'UTR region of the ZAM retrotrasposon of D. melanogaster as "insulator" to guarantee transgene high expression levels |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887081A2 DNA Sequences |
| 02/13/2008 | EP1887080A1 Endothelized artificial matrix comprising a fibrin gel, which is a superproducer of proangiogenic factors |
| 02/13/2008 | EP1887079A1 Genetically modified plants synthesizing starch with increased swelling power |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1886685A1 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 02/13/2008 | EP1886582A2 Method of preparing a heat-treated product |
| 02/13/2008 | EP1885889A2 Methods of monitoring functional status of transplants using gene panels |
| 02/13/2008 | EP1885880A2 Amplification and cloning of single dna molecules using rolling circle amplification |
| 02/13/2008 | EP1885867A2 Novel methods |
| 02/13/2008 | EP1885863A2 Methods for delivering genes |
| 02/13/2008 | EP1885862A2 Safflower with elevated gamma-linolenic acid |
| 02/13/2008 | EP1885861A2 Methods and compositions to enhance plant breeding |
| 02/13/2008 | EP1885860A2 Regulated vectors for selection of cells exhibiting desired phenotypes |
| 02/13/2008 | EP1885859A1 Controlled electroporation and mass transfer across cell membranes in tissue |
| 02/13/2008 | EP1885858A2 Treatment of disease using an improved regulated expression system |
| 02/13/2008 | EP1885857A1 Cells or plants having a producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same |
| 02/13/2008 | EP1885856A1 Transposition of maize ac/ds elements in vertebrates |
| 02/13/2008 | EP1885855A2 Cytokine receptor modulators and uses thereof |
| 02/13/2008 | EP1885854A2 Methods and sequences to suppress primate huntington gene expression |
| 02/13/2008 | EP1885853A2 Biological detection system and method |